🇺🇸 FDA
Pipeline program

S95012 concentrate solution for infusion 400mg/ 16 ml, Gazyvaro 1,000 mg concentrate for solution for infusion.

CL1-95012-001

Phase 2 small_molecule active

Quick answer

S95012 concentrate solution for infusion 400mg/ 16 ml, Gazyvaro 1,000 mg concentrate for solution for infusion. for Soild Tumors is a Phase 2 program (small_molecule) at Institut für biomedizinische Analytik NMR-Imaging GmbH with 1 ClinicalTrials.gov record(s).

Program details

Company
Institut für biomedizinische Analytik NMR-Imaging GmbH
Indication
Soild Tumors
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials